References

  1. Chatham K, Marshall C, Campbell IA, Prescott RJ. The Flutter VRP1device for post -thoracotomy patients. Physiotherapy. 1993;79(2):95–98.
  2. Pryor JA. Physiotherapy for airway clearance in adults.  Eur Respir J. 1999;14(6):1418-24.
  3. Volsko, T. Airway clearance therapy finding the evidence. Resp Car. 2013;(58)10:1669-78.
  4. VanFleet, H. Dunn D, McNinch N, et al. Evaluation of functional characteristics of 4 oscillatory positive pressure devices in a simulated cystic fibrosis model. Res Care. In Print.
  5. Myers TR. Positive expiratory pressure and oscillatory positive expiratory pressure therapies. Resp Care. 2007;52(10):1308-1326.
  6. Weibel in: Crystal, West, Weibel, Barnes. The Lung: Scientific Foundations; Lippencott; New York. 2000
  7. Ionescu, C et al. Assessment of the airway alterations by means of a fractal ladder network model  (Conference Paper) IFAC World Congress; Milano; Italy; 28 August 2011.
  8. Bansil R, Stanley, E. LaMont, JT. Mucin biophysics. Annu. Rev. Physiol. 1995;57:635–657.
  9. Boucher, RC. Molecular insights into the physiology of the ‘thin film’ of airway surface liquid. J. Physiol. 1999;516:631–638.
  10. Carson JL, Collier AM, Knowles A. et al. Morphometric aspects of ciliary distribution and ciliogenesis in human nasal epithelium. Proc Natl Acad Sci. 1981;78:6996–6999.
  11. Collins Dictionary of Biology, 3rd ed. © W. G. Hale, V. A. Saunders, J. P. Margham 2005
  12. Warwick WJ. Mechanisms of mucous transport. Eur J Respir Dis Suppl 1983;64(Suppl 127):162-167.
  13. Rubin BK. Physiology of airway mucus clearance. Respir Care. 2002; 47(7): 761-768.
  14. Carson JL, Collier AM, Knowles MR, Boucher RC, Rose JG. Morphometric aspects of ciliary distribution and ciliogenesis in human nasal epithelium. Proc Natl Acad Sci. 1981;78:6996–6999.
  15. Zaugg M, Lucchinetti E. Respiratory function in the elderly. Anesthesiol Clin North America. 2000;18(1):47-58.
  16. Hernandez ML, Harris B, Lay JC, et al. Comparative airway inflammatory response of normal volunteers to ozone and lipopolysaccharide challenge. Inhal Toxicol. 2010; 22(8):648-656.
  17. Hadjikoutis S, Wiles CM. Respiratory complications related to bulbar dysfunction in motor neuron disease. Acta Neurol Scand. 2001;103(4):207-213.
  18. Wanner A, Salathe M, O’Riordan TG. Mucociliary clearance in the airways. Am J Respir Crit Care Med. 1996;154(6 Pt 1):1868–902.
  19. Irwin RS, Rosen MJ, Braman SS. Cough. A comprehensive review. Arch Intern Med. 1977;137(9):1186-91.
  20. Mello CJ, Irwin RS, Curley FJ. Predictive values of the character, timing, andcomplications of chronic cough in diagnosing its cause. Arch Intern Med. 1996;156(9):997-1003.
  21. Volsko TA, DiFiore J, Chatburn RL. Performance comparison of two oscillating positive expiratory pressure devices: Acapella versus flutter. Resp Care. 2003;48(2):124-130.
  22. McIlwaine M. Physiotherapy and airway clearance techniques and devices. Paediatr Respir Rev. 2006;7(Suppl):S220–S222.
  23. Oostveen E. Macleod D, Lorino R, et. al. The forced oscillation technique in clinical practice: methodology, recommendations and future developments, Eur Respir J. 2003;22:1026–1041.
  24. Larson EB. N of 1 clinical trials a technique for improving medical therapeutics (specialty conference). West J Med. 1990;152:52-56.
  25. Groth S, Stafanger G, Dirksen H, et al. Positive expiratory pressure (PEP-mask) physiotherapy improves ventilation and reduces volume of trapped gas in cystic fibrosis. Bull Eur Physiopathol Respir. 1985;21(4):339–343.
  26. McCool FD, Rosen MJ. Nonpharmacologic airway clearance therapies: ACCP evidence-based clinical practice guidelines. Chest. 2006 Jan;129(1 Suppl):250S-259S. Review. PubMed PMID: 16428718.
  27. Guyatt GH, Keller JL, Jaeschke R, Rosenbloom D, Adachi JD, Newhouse MT. The n-of-1 randomized controlled clinical trial: clinical usefulness. Out three-year experience. Ann Intern Med. 1990;112(4): 293-299.
  28. Guyatt G, Sackett D, Adachi J, Roberts R, Chong J, Rosenbloom D, Keller J. A clinician’s guide for conducting randomized trials in individual patients. CMAJ. 1988;139(6):497-503.
  29. J Bourbeau, M Julien, F Maltais, Chronic Obstructive Pulmonary Disease axis of the Respiratory Network Fonds de la Recherche en Santé du Québec, et al. Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention Arch Intern Med. 163 (5) (2003)
  30. FW Ko, DL Dai, J Ngai, et al. Effect of early pulmonary rehabilitation on health care utilization and health status in patients hospitalized with acute exacerbations of COPD Respirology. 16 (4) (2011)
  31. Nowobilski, R. et al. Efficacy of physical therapy methods in airway clearance in patients with chronic obstructive pulmonary disease A critical review; 2010; 120 (11)
  32. Stoller JK. The effectiveness of respiratory care protocols. Respir Care. 2004;49(7):761-5.
  33. Guyatt GH, Keller JL, Jaeschke R, Rosenbloom D, Adachi JD, Newhouse MT. The n-of-1 randomized controlled clinical trial: clinical usefulness. Out three-year experience. Ann Intern Med. 1990;112(4): 293-299.
  34. Larson EB. N of 1 clinical trials a technique for improving medical therapeutics (specialty conference). West J Med. 1990;152:52-56.